149 related articles for article (PubMed ID: 12457717)
1. Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes.
Kok SH; Hong CY; Kuo MY; Lee CH; Lee JJ; Lou IU; Lee MS; Hsiao M; Lin SK
Oral Oncol; 2003 Jan; 39(1):19-26. PubMed ID: 12457717
[TBL] [Abstract][Full Text] [Related]
2. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells.
Liu XH; Blazsek I; Comisso M; Legras S; Marion S; Quittet P; Anjo A; Wang GS; Misset JL
Eur J Cancer; 1995 Jun; 31A(6):953-63. PubMed ID: 7646929
[TBL] [Abstract][Full Text] [Related]
3. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
[TBL] [Abstract][Full Text] [Related]
4. Effect of norcantharidin on the human breast cancer Bcap-37 cells.
Liu D; Shi P; Yin X; Chen Z; Zhang X
Connect Tissue Res; 2012; 53(6):508-12. PubMed ID: 22606958
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro.
Yi SN; Wass J; Vincent P; Iland H
Leuk Res; 1991; 15(10):883-6. PubMed ID: 1921448
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
[TBL] [Abstract][Full Text] [Related]
8. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio.
Kok SH; Cheng SJ; Hong CY; Lee JJ; Lin SK; Kuo YS; Chiang CP; Kuo MY
Cancer Lett; 2005 Jan; 217(1):43-52. PubMed ID: 15596295
[TBL] [Abstract][Full Text] [Related]
9. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
10. Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage of initiation protein Cdc6 in HL-60 cells.
Li JL; Cai YC; Liu XH; Xian LJ
Anticancer Drugs; 2006 Mar; 17(3):307-14. PubMed ID: 16520659
[TBL] [Abstract][Full Text] [Related]
11. Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells.
Chen S; Qu X; Wan P; Li QW; Wang Z; Guo F; Bai L; Hu Z; Tan W; Li J
Am J Chin Med; 2013; 41(3):665-82. PubMed ID: 23711148
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
Yu CC; Ko FY; Yu CS; Lin CC; Huang YP; Yang JS; Lin JP; Chung JG
Int J Oncol; 2012 Sep; 41(3):1050-60. PubMed ID: 22684608
[TBL] [Abstract][Full Text] [Related]
13. Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect.
Chen YJ; Tsai YM; Kuo CD; Ku KL; Shie HS; Liao HF
Life Sci; 2009 Oct; 85(17-18):642-51. PubMed ID: 19765597
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways.
An WW; Gong XF; Wang MW; Tashiro S; Onodera S; Ikejima T
Acta Pharmacol Sin; 2004 Nov; 25(11):1502-8. PubMed ID: 15525474
[TBL] [Abstract][Full Text] [Related]
15. Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells.
Lin CL; Chen CM; Lin CL; Cheng CW; Lee CH; Hsieh YH
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1867-1876. PubMed ID: 28760656
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
Ren J; Li G; Zhao W; Lin L; Ye T
World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
[TBL] [Abstract][Full Text] [Related]
17. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of DNA damage induced by norcantharidin in human cultured lymphocytes.
Khabour OF; Enaya FM; Alzoubi K; Al-Azzam SI
Drug Chem Toxicol; 2016; 39(3):303-6. PubMed ID: 26599593
[TBL] [Abstract][Full Text] [Related]
19. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
